North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules
Recommendations
As issued by the authors
Directed ablative therapy (DAT) for benign non-functional thyroid nodules (BNFTNs) is a first-line management strategy for relief of compressive and cosmetic symptoms, as an alternative to surgical excision or observation
Success of ablation relies on careful patient selection and the technical expertise of the treating physician
DAT is supported for benign symptomatic thyroid nodules, appropriately selected growing nodules with impending symptoms, or indeterminate cytology with negative molecular markers
Original publication
North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules. Endocr Pract. Published 12 May 2026. doi:10. 1016/ j. eprac. 2026. 05. 002
Composed by AI from the published abstract and checked against it. How Briefs are made →